Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,510 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01475266 | Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) | terminated | Phase 2 / Phase 3 | 51 | Nippon Kayaku Co., Ltd.INDUSTRY | 2 | Mar 29, 2017 | clinicaltrials |
| NCT02050451 | Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy | completed | N/A | 60 | Vanderbilt UniversityOTHER | 1 | Mar 29, 2017 | clinicaltrials |
| NCT01444456 |
| Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia |
| completed |
| — |
| 1,262 |
| AmgenINDUSTRY |
| 9 |
| Mar 20, 2017 |
| clinicaltrials |
| NCT01956253 | Single Subject Neratinib in Bladder Cancer (NRR) | no longer available | — | — | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 14, 2017 | clinicaltrials |
| NCT00957424 | Acceptability of Less Harmful Alternatives to Cigarettes | completed | N/A | 67 | Roswell Park Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01828736 | Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma(CVH-CT02) | completed | Phase 2 | 61 | Association Pour La Recherche des Thérapeutiques Innovantes en CancérologieOTHER | 2 | Feb 6, 2017 | clinicaltrials |
| NCT02326168 | PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer | completed | Early Phase 1 | 25 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT01142102 | Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer(BOLART) | completed | N/A | 50 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Jan 24, 2017 | clinicaltrials |
| NCT00003657 | High-dose ICE With Amifostine | completed | Phase 2 | 24 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 20, 2017 | clinicaltrials |
| NCT00578006 | Internet-based System for Cancer Patients to Self-report Toxicity | completed | N/A | 1,007 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 10, 2017 | clinicaltrials |
| NCT01410565 | Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer | terminated | Phase 3 | 66 | Spectrum Pharmaceuticals, IncINDUSTRY | 2 | Dec 13, 2016 | clinicaltrials |
| NCT01007058 | Markers of Response to Intravesical Bladder Cancer Therapy | completed | — | 150 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT00565227 | Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. | terminated | Phase 1 | 12 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 2, 2016 | clinicaltrials |
| NCT01162785 | 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer | completed | Phase 1 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT02252393 | Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Nov 9, 2016 | clinicaltrials |
| NCT02572804 | Comparing Rectus Sheath Catheter to Epidural Post Cystectomy | unknown | N/A | 160 | Vancouver Coastal HealthOTHER_GOV | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01170299 | Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer | completed | N/A | 177 | Royal Marsden NHS Foundation TrustOTHER | 1 | Nov 1, 2016 | clinicaltrials |
| NCT02951078 | A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer | unknown | Phase 3 | 172 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Nov 1, 2016 | clinicaltrials |
| NCT00808639 | Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma | completed | Phase 2 | 39 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 24, 2016 | clinicaltrials |
| NCT01454089 | A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer | completed | Phase 2 | 183 | Achieve Life SciencesINDUSTRY | 7 | Oct 7, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00310115 | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | completed | — | 469 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT02233842 | Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors | completed | — | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 12, 2016 | clinicaltrials |
| NCT02149862 | FIRBladd - Use of Infrared Spectroscopy in the Diagnosis of Bladder Tumors(FIRBladd) | completed | N/A | 137 | Rennes University HospitalOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT02886897 | A Study of Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors | unknown | Phase 1 / Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Sep 1, 2016 | clinicaltrials |
| NCT02030574 | Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin | terminated | Phase 2 | 2 | Brown UniversityOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT00022633 | S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract | terminated | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Aug 11, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02846467 | Information Improvement for Surgical Patients Through Portable Video Media | completed | N/A | 193 | Hospital Universitario Puerto RealOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT02457650 | T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies | unknown | Phase 1 | 36 | Shenzhen Second People's HospitalOTHER | 1 | Aug 3, 2016 | clinicaltrials |
| NCT00028756 | Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium | completed | Phase 3 | 285 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Aug 2, 2016 | clinicaltrials |
| NCT00003565 | Docetaxel in Treating Patients With Solid Tumors | completed | Phase 2 | 109 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT00014534 | Combination Chemotherapy in Treating Patients With Bladder Cancer | completed | Phase 3 | 42 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00003623 | High-Dose Multivitamins Compared to a Placebo in Preventing the Recurrence of Cancer in Patients With Early Stage Bladder Cancer | completed | Phase 3 | 21 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT02360618 | Metformin and Simvastatin Use in Bladder Cancer | unknown | Phase 2 | 44 | London Health Sciences CentreOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT01339000 | Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | terminated | Phase 2 | 1 | National Cancer Institute (NCI)NIH | 1 | Jun 22, 2016 | clinicaltrials |
| NCT00645593 | Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer | completed | Phase 2 | 89 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT00729287 | Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer(SELEBLAT) | completed | Phase 3 | 276 | KU LeuvenOTHER | 1 | May 12, 2016 | clinicaltrials |
| NCT02718742 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation After Cisplatin-Based Chemotherapy and Surgery in Treating Patients With High-Risk Bladder Cancer | withdrawn | Phase 2 | 0 | Mayo ClinicOTHER | 1 | Apr 18, 2016 | clinicaltrials |
| NCT00506155 | Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer | completed | Phase 2 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT01182168 | Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies | completed | Phase 1 | 12 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT00365508 | Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking | completed | Phase 4 | 642 | Fox Chase Cancer CenterOTHER | 1 | Mar 29, 2016 | clinicaltrials |
| NCT02716961 | Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer | unknown | N/A | 208 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Mar 24, 2016 | clinicaltrials |
| NCT00234494 | Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer | completed | Phase 2 | 45 | Christopher Sweeney, MBBSOTHER | 1 | Mar 14, 2016 | clinicaltrials |
| NCT00847015 | Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer | completed | Phase 2 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 29, 2016 | clinicaltrials |
| NCT00469066 | Cone Beam CT Scanning in Lung and Bladder Cancer. | completed | — | 22 | AHS Cancer Control AlbertaOTHER | 1 | Feb 24, 2016 | clinicaltrials |
| NCT00587964 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | completed | Phase 2 | 51 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 22, 2016 | clinicaltrials |
| NCT01916109 | Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer | terminated | Phase 2 | 4 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 12, 2016 | clinicaltrials |
| NCT02452944 | Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block | completed | N/A | 62 | Gachon University Gil Medical CenterOTHER | 0 | Feb 8, 2016 | clinicaltrials |
| NCT00397488 | Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium | completed | Phase 2 | 78 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 25, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Mar 29, 2017source: clinicaltrials